通心络胶囊 - 百度百科
为理血剂，具有益气活血，通络止痛之功效。 主治冠心病心绞痛属心气虚乏，血瘀络阻证，症见胸部憋闷，刺痛，绞痛，固定不移，心悸自汗，气短乏力，舌质紫黯或有瘀斑，脉细涩或结代。 亦用于气虚血瘀络阻型中风病，症见半身不遂或偏身麻木，口舌歪斜，言语不利。 2023年10月24日，通心络治疗急性心梗循证研究在国际顶级医学期刊《JAMA》（美国医学会杂志）发布。
Traditional Chinese Medicine Compound (Tongxinluo) and …
2023年10月24日 · Importance: Tongxinluo, a traditional Chinese medicine compound, has shown promise in in vitro, animal, and small human studies for myocardial infarction, but has not been rigorously evaluated in large randomized clinical trials.
Tongxinluo capsule as a multi-functional traditional Chinese …
2024年7月15日 · The innovative traditional Chinese medicine Tongxinluo (TXL) developed under the guidance of traditional Chinese medicine theory of collateral diseases has good therapeutic effects on various cardiovascular diseases.
Trial of Chinese medicine compound Tongxinluo shows intriguing …
2023年10月30日 · A clinical trial led by Yuejin Yang of the Chinese Academy of Medical Sciences and Peking Union Medical College, China, has concluded that a Chinese traditional medicine compound, Tongxinluo,...
Tongxinluo capsule in combination with conventional therapies for ... - LWW
2023年10月13日 · This study aimed to assess the efficacy and safety of Tongxinluo capsule (TXLC) in combination with conventional therapies for treating stable angina pectoris (SAP) through a comprehensive meta-analysis and systematic review.
Tongxinluo capsule as supplementation and cardiovascular …
2022年5月10日 · Ethnopharmacological relevance: Tongxinluo Capsule (TXLC) is a well-known traditional Chinese medicine prescription with effects of tonifying Qi and activating blood based on the Chinese herbal medicine theory that has been recommended as routine adjuvant treatment in patients with coronary heart disease (CHD) in China.
Tongxinluo (Tong xin luo or Tong‐xin‐luo) capsule for unstable …
Tongxinluo capsule is a medicine consisting of traditional Chinese herbs and insects used for cardiovascular diseases in China and some other Asian countries.
Nature重磅：中药通心络胶囊治疗血管病系统疾病疗效显著，获得 …
2019年4月3日 · 通心络胶囊是防治冠心病心绞痛、心肌梗死、脑卒中等心脑血管病的代表药，目前已在临床运用20多年，每年被数十万名心脑血管病患者服用。
Systematic Review of Tongxinluo Capsule on the Therapeutic …
2021年12月6日 · Tongxinluo (TXL) capsule is a traditional Chinese medicine compound preparation approved by the State Food and Drug Administration of China in 2010. TXL possesses the effects of invigorating Qi, promoting blood circulation, removing blood stasis, and relieving pain, which has achieved significant therapeutic effect on cardiovascular and ...
Potential Effectiveness of Chinese Patent Medicine Tongxinluo …
2018年8月3日 · Tongxinluo Capsule (TXL), passed appraisal by National Fund for new drug research and registered in the State Food and Drug Administration of China, is a formally classical Chinese patent medicine in treating unstable angina pectoris and acute coronary syndrome (Wang et al., 2003; Ma et al., 2009).